nderstanding the Impact of General Vaccine Attitudes on the Intent for Early COVID-19 Vaccination
- Boyle, Glen Nowak, R. Kinder, R. Iachan, and J. Dayton, “Understanding the Impact of General Vaccine Attitudes on the Intent for Early COVID-19 Vaccination,” Vaccines, 2023, 11(2), 235; https://doi.org/10.3390/vaccines11020235.
Abstract: This study provides a more comprehensive assessment of factors influencing willingness to get an early COVID-19 and the relative contribution of general vaccine attitudes, compared to demographics, perceived threat and institutional trust. Monthly national surveys were conducted between June and November 2020 using a national consumer panel of U.S. adults (n = 6185). By late November, only 24% of respondents said they were very likely to get a Food and Drug Administration (FDA)-approved COVID-19 vaccine as soon as it became available. While COVID-19 risk perceptions, confidence and trust in key institutions and information sources, and some demographic variables, were predictive of early vaccination intent, general beliefs regarding vaccines played a significant role, even compared to demographics, perceived risk and institutional trust. This lesson from the COVID-19 experience could help inform public health communications in future epidemics.